Caplin steriles signs license, supply agreement with Baxter for injectable portfolio
Chennai: Pharma Major, Caplin Point Laboratories said that its wholly owned subsidiary Caplin Steriles Limited has entered into a license and supply agreement with Baxter Healthcare Corporation for five generic injectable ANDAs.
Read Also: USFDA completes inspection at Caplin Point Lab’s sterile injectable facility in Tamil Nadu
Commenting on the transaction, Mr C.C.Paarthipan, Chairman, Caplin Point Laboratories Limited, said ''We are glad to enhance our partnership with Baxter with this agreement. All these ANDAs have been developed in-house, and we're keen to license them to Baxter, who have an excellent sales and marketing infrastructure in the US for commercialization of these products.''
Specific terms of the agreement were not disclosed.
Read Also: Baxter gets USFDA nod to Cardiovascular Medicine Eptifibatide
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd